Transcranial magnetic stimulation for the treatment of anxiety disorder

Carregando...
Imagem de Miniatura
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
DOVE MEDICAL PRESS LTD
Citação
NEUROPSYCHIATRIC DISEASE AND TREATMENT, v.15, p.2743-2761, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Anxiety is currently one of the main mood changes and can impair the quality of life of the individual when associated with other neurological or psychiatric disorders. Neuromodulation has been highlighted as a form of treatment of several pathologies, including those involving anxiety symptoms. Among the neuromodulatory options with the potential to improve mood changes, we highlight repetitive transcranial magnetic stimulation (rTMS). rTMS is a viable therapeutical option for neuropsychiatric dysfunctions of high prevalence and is important for the understanding of pathological and neuropsychological adaptation processes. Even with this potential, and high relevance of intervention, we observe the scarcity of literature that covers this subject. The objective of this study was to carry out a survey of the current literature, using scientific databases for the last five years. We found 32 studies reporting the effects of rTMS on anxiety, 7 on anxiety disorders and 25 on anxiety symptoms as comorbidities of neurological or psychiatric disorders. This survey suggests the need for further studies using TMS for anxiety in order to seek strategies that minimize these anxiety effects on the quality of life of the victims of this disorder.
Palavras-chave
transcranial magnetic stimulation, anxiety disorders, review, treatment
Referências
  1. ARAUJO HA, 2011, REV MED SAO PAULO, V90, P3
  2. Balconi M, 2013, PSYCHIAT RES, V209, P554, DOI 10.1016/j.psychres.2013.03.032
  3. BARKER AT, 1991, J CLIN NEUROPHYSIOL, V8, P26, DOI 10.1097/00004691-199101000-00005
  4. BARKER AT, 1987, NEUROSURGERY, V20, P100
  5. Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207
  6. Bashir S, 2010, PM&R, V2, pS253, DOI 10.1016/j.pmrj.2010.10.015
  7. Berlim MT, 2011, J AFFECT DISORDERS, V130, P312, DOI 10.1016/j.jad.2010.10.011
  8. Bilici S, 2015, EUR ARCH OTO-RHINO-L, V272, P337, DOI 10.1007/s00405-013-2851-z
  9. Boggio PS, 2010, J CLIN PSYCHIAT, V71, P992, DOI 10.4088/JCP.08m04638blu
  10. Borkovec TD, 2002, J CONSULT CLIN PSYCH, V70, P288, DOI 10.1037//0022-006X.70.2.288
  11. Cabrera CC, 2005, PRATICA PSIQUIATRICA, P283
  12. Cantone M, 2017, ASN NEURO, V9, DOI 10.1177/1759091417711512
  13. Cohen H, 2004, AM J PSYCHIAT, V161, P515, DOI 10.1176/appi.ajp.161.3.515
  14. Concerto C, 2015, INT J PSYCHIAT CLIN, V19, P253, DOI 10.3109/13651501.2015.1084329
  15. Diefenbach GJ, 2016, BRIT J PSYCHIAT, V209, P222, DOI 10.1192/bjp.bp.115.168203
  16. Diefenbach GJ, 2013, J AFFECT DISORDERS, V151, P365, DOI 10.1016/j.jad.2013.05.094
  17. Dilkov D, 2017, PROG NEURO-PSYCHOPH, V78, P61, DOI 10.1016/j.pnpbp.2017.05.018
  18. Durmaz O, 2017, PSYCHIAT CLIN PSYCH, V27, P14, DOI 10.1080/24750573.2017.1293239
  19. Elbeh KAM, 2016, PSYCHIAT RES, V238, P264, DOI 10.1016/j.psychres.2016.02.031
  20. Epstein CM, 2007, CLIN NEUROPHYSIOL, V118, P2189, DOI 10.1016/j.clinph.2007.07.010
  21. George MS, 2000, BIOL PSYCHIAT, V48, P962, DOI 10.1016/S0006-3223(00)01048-9
  22. Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832
  23. Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000
  24. Hegde S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00034
  25. Herrmann MJ, 2017, BRAIN STIMUL, V10, P291, DOI 10.1016/j.brs.2016.11.007
  26. Iannone A, 2016, ARQ NEURO-PSIQUIAT, V74, P829, DOI 10.1590/0004-282X20160115
  27. Kaur M, 2019, PSYCHIAT RES, V271, P335, DOI 10.1016/j.psychres.2018.12.002
  28. Kim YI, 2016, PSYCHIAT INVEST, V13, P622, DOI 10.4306/pi.2016.13.6.622
  29. Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1
  30. Lanza Giuseppe, 2018, Ther Adv Neurol Disord, V11, p1756286418759973, DOI 10.1177/1756286418759973
  31. Lanza G, 2017, SLEEP MED, V31, P49, DOI 10.1016/j.sleep.2016.05.010
  32. Lefaucheur JP, 2006, NEUROPHYSIOL CLIN, V36, P105, DOI 10.1016/j.neucli.2006.08.011
  33. Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021
  34. Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816
  35. Lin H, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011235
  36. Lin YC, 2015, CHINESE MED J-PEKING, V128, P1728, DOI 10.4103/0366-6999.159344
  37. Loo CK, 2003, PSYCHOL MED, V33, P997, DOI 10.1017/S0033291703007955
  38. Lu RL, 2018, NEUROSCI LETT, V684, P67, DOI 10.1016/j.neulet.2018.07.008
  39. Luber BM, 2017, NEUROIMAGE, V148, P1, DOI 10.1016/j.neuroimage.2016.12.083
  40. Ma XY, 2014, CHINESE MED J-PEKING, V127, P601, DOI 10.3760/cma.j.issn.0366-6999.20131994
  41. Mak ADP, 2017, BRAIN STIMUL, V10, P378
  42. Malavera A, 2016, J PAIN, V17, P911, DOI 10.1016/j.jpain.2016.05.003
  43. Mantovani A, 2013, J AFFECT DISORDERS, V144, P153, DOI 10.1016/j.jad.2012.05.038
  44. Miniussi C, 2011, NEUROPSYCHOL REHABIL, V21, P579, DOI 10.1080/09602011.2011.562689
  45. Munchau A, 2002, NEUROLOGY, V59, P1789, DOI 10.1212/01.WNL.0000036615.25044.50
  46. Nielson DM, 2015, ARCH PHYS MED REHAB, V96, pS138, DOI 10.1016/j.apmr.2014.09.010
  47. Noh TS, 2017, OTOL NEUROTOL, V38, P296, DOI 10.1097/MAO.0000000000001266
  48. Oznur T, 2014, NEUROSCIENCES, V19, P29
  49. Paes F, 2011, CNS NEUROL DISORD-DR, V10, P610, DOI 10.2174/187152711796234943
  50. Passard A, 2007, BRAIN, V130, P2661, DOI 10.1093/brain/awm189
  51. Pennisi G, 2015, CLIN NEUROPHYSIOL, V126, P851, DOI 10.1016/j.clinph.2014.09.001
  52. Prasko J, 2007, NEUROENDOCRINOL LETT, V28, P33
  53. Pretalli JB, 2012, PSYCHIAT CLIN NEUROS, V66, P344, DOI 10.1111/j.1440-1819.2012.02341.x
  54. Reyes-Lopez J, 2018, REV BRAS PSIQUIATR, V40, P97, DOI 10.1590/1516-4446-2016-2112
  55. Ricci Raffaella, 2008, Ther Clin Risk Manag, V4, P1127
  56. Rollnik JD, 2000, NEUROREPORT, V11, P4013, DOI 10.1097/00001756-200012180-00022
  57. Rossi S, 2007, J NEUROL NEUROSUR PS, V78, P857, DOI 10.1136/jnnp.2006.105007
  58. Sagliano L, 2016, SOC COGN AFFECT NEUR, V11, P1992, DOI 10.1093/scan/nsw105
  59. Sun W, 2012, EPILEPSIA, V53, P1782, DOI 10.1111/j.1528-1167.2012.03626.x
  60. Tovar-Perdomo S, 2017, J AFFECT DISORDERS, V217, P112, DOI 10.1016/j.jad.2017.03.075
  61. Vicario CM, 2019, NEUROSCI BIOBEHAV R, V96, P219, DOI 10.1016/j.neubiorev.2018.12.012
  62. Vidor LP, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-42
  63. Watts BV, 2012, BRAIN STIMUL, V5, P38, DOI 10.1016/j.brs.2011.02.002
  64. Weir K, 2015, APA, V46, P50
  65. White D, 2015, ANN CLIN PSYCHIATRY, V27, P192
  66. Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55
  67. Zhang TH, 2019, BRAIN STIMUL, V12, P103, DOI 10.1016/j.brs.2018.09.007